Safety, Efficacy and Cardiovascular Benefits of Combination Therapy with Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Article (Faculty180)

cited authors

  • Mousavi, A; Shojaei, S; Soleimani, H; Semirani-Nezhad, D; Ebrahimi, P; Zafari, A; Ebrahimi, R; Roozbehi, K; Harrison, A; Syed, M; Kampaktsis, P; Kuno, T; Heffron, S; Samsky, M; Askari, M K; Hosseini, K

authors

published in